These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7650033)

  • 1. The presence of beta-D-ribosyl-1-monophosphodecaprenol in mycobacteria.
    Wolucka BA; de Hoffmann E
    J Biol Chem; 1995 Aug; 270(34):20151-5. PubMed ID: 7650033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recognition of the lipid intermediate for arabinogalactan/arabinomannan biosynthesis and its relation to the mode of action of ethambutol on mycobacteria.
    Wolucka BA; McNeil MR; de Hoffmann E; Chojnacki T; Brennan PJ
    J Biol Chem; 1994 Sep; 269(37):23328-35. PubMed ID: 8083238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biosynthesis of D-arabinose in mycobacteria - a novel bacterial pathway with implications for antimycobacterial therapy.
    Wolucka BA
    FEBS J; 2008 Jun; 275(11):2691-711. PubMed ID: 18422659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decaprenylphosphoryl arabinofuranose, the donor of the D-arabinofuranosyl residues of mycobacterial arabinan, is formed via a two-step epimerization of decaprenylphosphoryl ribose.
    Mikusová K; Huang H; Yagi T; Holsters M; Vereecke D; D'Haeze W; Scherman MS; Brennan PJ; McNeil MR; Crick DC
    J Bacteriol; 2005 Dec; 187(23):8020-5. PubMed ID: 16291675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GtrA Protein Rv3789 Is Required for Arabinosylation of Arabinogalactan in Mycobacterium tuberculosis.
    Kolly GS; Mukherjee R; Kilacsková E; Abriata LA; Raccaud M; Blaško J; Sala C; Dal Peraro M; Mikušová K; Cole ST
    J Bacteriol; 2015 Dec; 197(23):3686-97. PubMed ID: 26369580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new interpretation of the structure of the mycolyl-arabinogalactan complex of Mycobacterium tuberculosis as revealed through characterization of oligoglycosylalditol fragments by fast-atom bombardment mass spectrometry and 1H nuclear magnetic resonance spectroscopy.
    Besra GS; Khoo KH; McNeil MR; Dell A; Morris HR; Brennan PJ
    Biochemistry; 1995 Apr; 34(13):4257-66. PubMed ID: 7703239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the core lipopeptide of the glycopeptidolipid surface antigens in rough mutants of Mycobacterium avium.
    Belisle JT; McNeil MR; Chatterjee D; Inamine JM; Brennan PJ
    J Biol Chem; 1993 May; 268(14):10510-6. PubMed ID: 8486703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biosynthesis of d-arabinose in Mycobacterium smegmatis: specific labeling from d-glucose.
    Klutts JS; Hatanaka K; Pan YT; Elbein AD
    Arch Biochem Biophys; 2002 Feb; 398(2):229-39. PubMed ID: 11831854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and characterization of the major form of polyprenyl-phospho-mannose from Mycobacterium smegmatis.
    Wolucka BA; de Hoffmann E
    Glycobiology; 1998 Oct; 8(10):955-62. PubMed ID: 9719676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and active expression of the Mycobacterium tuberculosis gene encoding 5-phospho-{alpha}-d-ribose-1-diphosphate: decaprenyl-phosphate 5-phosphoribosyltransferase, the first enzyme committed to decaprenylphosphoryl-d-arabinose synthesis.
    Huang H; Scherman MS; D'Haeze W; Vereecke D; Holsters M; Crick DC; McNeil MR
    J Biol Chem; 2005 Jul; 280(26):24539-43. PubMed ID: 15878857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional identification of MSMEG_6402 protein from Mycobacterium smegmatis in decaprenylphosphoryl-D-arabinose biosynthesis.
    Jiang T; Cai L; Zhao X; He L; Ma Y; Zang S; Zhang C; Li X; Xin Y
    Microb Pathog; 2014 Nov; 76():44-50. PubMed ID: 25223716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyprenylphosphate-pentoses in mycobacteria are synthesized from 5-phosphoribose pyrophosphate.
    Scherman MS; Kalbe-Bournonville L; Bush D; Xin Y; Deng L; McNeil M
    J Biol Chem; 1996 Nov; 271(47):29652-8. PubMed ID: 8939897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predominant structural features of the cell wall arabinogalactan of Mycobacterium tuberculosis as revealed through characterization of oligoglycosyl alditol fragments by gas chromatography/mass spectrometry and by 1H and 13C NMR analyses.
    Daffe M; Brennan PJ; McNeil M
    J Biol Chem; 1990 Apr; 265(12):6734-43. PubMed ID: 2108960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Truncated structural variants of lipoarabinomannan in ethambutol drug-resistant strains of Mycobacterium smegmatis. Inhibition of arabinan biosynthesis by ethambutol.
    Khoo KH; Douglas E; Azadi P; Inamine JM; Besra GS; Mikusová K; Brennan PJ; Chatterjee D
    J Biol Chem; 1996 Nov; 271(45):28682-90. PubMed ID: 8910503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biosynthesis of the galactan component of the mycobacterial cell wall.
    Mikusová K; Yagi T; Stern R; McNeil MR; Besra GS; Crick DC; Brennan PJ
    J Biol Chem; 2000 Oct; 275(43):33890-7. PubMed ID: 10934214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galactosamine in walls of slow-growing mycobacteria.
    Draper P; Khoo KH; Chatterjee D; Dell A; Morris HR
    Biochem J; 1997 Oct; 327 ( Pt 2)(Pt 2):519-25. PubMed ID: 9359425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the in vitro synthesized arabinan of mycobacterial cell walls.
    Xin Y; Lee RE; Scherman MS; Khoo KH; Besra GS; Brennan PJ; McNeil M
    Biochim Biophys Acta; 1997 Jun; 1335(3):231-4. PubMed ID: 9202184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of glycosylated beta-amino acids as new class of antitubercular agents.
    Tripathi RP; Tripathi R; Tiwari VK; Bala L; Sinha S; Srivastava A; Srivastava R; Srivastava BS
    Eur J Med Chem; 2002 Sep; 37(9):773-81. PubMed ID: 12350294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The embAB genes of Mycobacterium avium encode an arabinosyl transferase involved in cell wall arabinan biosynthesis that is the target for the antimycobacterial drug ethambutol.
    Belanger AE; Besra GS; Ford ME; Mikusová K; Belisle JT; Brennan PJ; Inamine JM
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11919-24. PubMed ID: 8876238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethambutol inhibition of glucose metabolism in mycobacteria: a possible target of the drug.
    Silve G; Valero-Guillen P; Quemard A; Dupont MA; Daffe M; Laneelle G
    Antimicrob Agents Chemother; 1993 Jul; 37(7):1536-8. PubMed ID: 8363387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.